Assessment of treatment response to bevacizumab (BEV) with MRI in recurrent malignant glioma (MG)

被引：0
|
作者：
Mohile, Nimish [1 ]
Abrey, Lauren [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
NEURO-ONCOLOGY | 2007年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [1] Bevacizumab in recurrent malignant glioma
    Lauren E. Abrey
    Current Neurology and Neuroscience Reports, 2008, 8 (3) : 233 - 234
  • [2] Treatment With Bevacizumab Plus Carboplatin for Recurrent Malignant Glioma
    Thompson, Eric M.
    Dosa, Edit
    Kraemer, Dale F.
    Neuwelt, Edward A.
    NEUROSURGERY, 2010, 67 (01) : 87 - 93
  • [3] Carboplatin and bevacizumab for recurrent malignant glioma
    Mrugala, Maciej M.
    Crew, Laurie K.
    Fink, James R.
    Spence, Alexander M.
    ONCOLOGY LETTERS, 2012, 4 (05) : 1082 - 1086
  • [4] MRI AND FET-PET DEMONSTRATE EARLY RESPONSE TO BEVACIZUMAB AND IRINOTECAN THERAPY IN RECURRENT MALIGNANT GLIOMA
    Schroeteler, J.
    Rapp, M.
    Ringelstein, A.
    Stoffels, G.
    Langen, K.
    Stummer, W.
    Steiger, H.
    Ewelt, C.
    Sabel, M.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1099 - 1099
  • [5] Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)
    Khasraw, M.
    Abrey, L. E.
    Lassman, A. B.
    Hormigo, A.
    Nolan, C.
    Gavrilovic, I. T.
    Mellinghoff, I. K.
    Reiner, A. S.
    DeAngelis, L. M.
    Omuro, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Impact of duration of bevacizumab (Bev) treatment in the prognosis of adults with recurrent malignant gliomas.
    Hamza, Mohamed Ali
    Conrad, Charles A.
    De Groot, John Frederick
    Gilbert, Mark R.
    Groves, Morris D.
    Yung, W. K. Alfred
    Puduvalli, Vinay K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Quantitative MRI assessment of glioma response to bevacizumab in a mouse model
    Zhang, Jinlong
    Wang, Shunan
    Liu, Heng
    Du, Xuesong
    Chen, Xiao
    Guo, Yu
    Zhang, Junfeng
    Fang, Jingqin
    Zhang, Weiguo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (10): : 14232 - 14243
  • [8] Single Agent Bevacizumab for Recurrent Malignant Glioma
    Cadoo, K.
    O'Brien, M.
    Grogan, L.
    Breathnach, O.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S588 - S588
  • [9] Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI
    Norbert Galldiks
    Marion Rapp
    Gabriele Stoffels
    Gereon R. Fink
    Nadim J. Shah
    Heinz H. Coenen
    Michael Sabel
    Karl-Josef Langen
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 22 - 33
  • [10] Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI
    Galldiks, Norbert
    Rapp, Marion
    Stoffels, Gabriele
    Fink, Gereon R.
    Shah, Nadim J.
    Coenen, Heinz H.
    Sabel, Michael
    Langen, Karl-Josef
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (01) : 22 - 33
12345